Author

Aoi Sugiyama

Hokkaido UniversityORCID 0000-0001-5211-5297Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Cassandra T. DavidiD· 1 shared Fei YaniD· 1 shared Gregory W. MoseleyiD· 1 shared Karyn L. WildeiD· 1 shared Katsumi MaenakaiD· 1 shared Masahiro Eguchi· 1 shared Megumi Onishi· 1 shared Mika HiroseiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Cassandra T. DavidORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJul 30, 2026

Rabies virus antagonizes interferon signaling by targeting phosphorylated STAT1 tetramers

Miku Minami, Aoi Sugiyama, Shatabdi Chakraborty…·Toyoyuki Ose

This study reveals how rabies virus P protein inhibits interferon signaling by selectively binding to phosphorylated STAT1 tetramers, stabilizing them and preventing DNA binding.

DOI 10.64898/2026.07.29.741124

experimental assay

𝕏 PostBluesky

MicrobiologyMicrobiology SpectrumPeer-reviewedFeb 22, 2024

A novel vaccine strategy using quick and easy conversion of bacterial pathogens to unnatural amino acid-auxotrophic suicide derivatives

Yuya Nagasawa, Momoko Nakayama, Yusuke Kato…·Masahiro Eguchi

This paper introduces a method to convert bacterial pathogens into live vaccines using unnatural amino acid-auxotrophic suicide derivatives, showing enhanced immunogenicity and safety.

4 citations

E. colihuman

𝕏 PostBluesky